Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
13.3%
% of MEDX's 30 holdings also in HART
6.1%
% of HART's 75 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.3% | 5.4% | 5.4% |
|
BRISTOL-MYERS SQUIBB CO | 5.6% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 5.0% | 5.3% | 5.0% |
|
PFIZER INC | 3.9% | 5.0% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to HART
|
ELI LILLY & CO | 12.0% |
|
ABBVIE INC | 9.5% |
 |
NOVARTIS AG-ADR | 6.9% |
|
AMGEN INC | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.7% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% |
 |
ALKERMES PLC | 4.6% |
|
MERCK & CO. INC. | 3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.8% |
|
REGENERON PHARMACEUTICALS | 2.7% |
MEDX Underweight Relative to HART
|
ABBOTT LABORATORIES | -5.7% |
|
ASTRAZENECA PLC | -5.6% |
|
BOSTON SCIENTIFIC CORP | -5.4% |
|
MEDTRONIC PLC | -5.4% |
|
NOVARTIS AG | -5.3% |
|
ALPHABET INC. CLASS A | -5.0% |
|
APPLE INC | -4.9% |
 |
SANOFI-AVENTIS | -4.0% |
 |
NOVO NORDISK A/S-B | -4.0% |
|
ELEVANCE HEALTH INC | -2.8% |